Laird Norton Wetherby Trust Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Laird Norton Wetherby Trust Company's PFE Position: Q2 2026 in Review
Laird Norton Wetherby Trust Company increased its Pfizer (PFE) stake by 3.9% in Q2 2026, buying an estimated $138K and bringing the position to 141,504 shares worth $3.41M. The position accounts for 0.07% of the portfolio, ranked #222.
Laird Norton Wetherby Trust Company first reported a position in PFE in Q4 2020 and has held it in 17 quarters since. The position peaked at $3.83M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Laird Norton Wetherby Trust Company held 141,504 shares of Pfizer worth $3.41M as of Q2 2026.
- Laird Norton Wetherby Trust Company bought 5,283 Pfizer shares in Q2 2026, an estimated $138K.
- Pfizer made up 0.07% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #222 holding.
- Laird Norton Wetherby Trust Company first reported a position in Pfizer in Q4 2020 and has held it in 17 quarters since.
- Laird Norton Wetherby Trust Company's Pfizer position peaked at $3.83M in Q1 2026.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.